These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1025 related items for PubMed ID: 33146847

  • 1. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X, Guo J, Zhou Q, Huang W, Xu C, Long X.
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [Abstract] [Full Text] [Related]

  • 2. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R, Yang M, Tan Y, Ding R, Li D.
    Comput Math Methods Med; 2021 Mar; 2021():6676692. PubMed ID: 33727952
    [Abstract] [Full Text] [Related]

  • 3. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
    Fan C, Du J, Liu N.
    Comput Math Methods Med; 2021 Mar; 2021():2649123. PubMed ID: 33688372
    [Abstract] [Full Text] [Related]

  • 4. Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.
    Mu G, Ji H, He H, Wang H.
    Breast Cancer; 2021 Mar; 28(2):513-526. PubMed ID: 33245478
    [Abstract] [Full Text] [Related]

  • 5. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.
    Liu J, Geng R, Yang S, Shao F, Zhong Z, Yang M, Ni S, Cai L, Bai J.
    Front Immunol; 2021 Mar; 12():788431. PubMed ID: 34970268
    [Abstract] [Full Text] [Related]

  • 6. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F, Fan Y, Hou J, Liu B, Zhang B, Shang Y, Chang Y, Cao P, Tan K.
    Aging (Albany NY); 2021 Sep 13; 13(17):21671-21699. PubMed ID: 34518441
    [Abstract] [Full Text] [Related]

  • 7. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H, Liu H, Hao Q, Liu X, Yao Y, Cao M.
    Front Immunol; 2022 Sep 13; 13():891175. PubMed ID: 35990668
    [Abstract] [Full Text] [Related]

  • 8. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T, Yang C, Dou R, Xiong B.
    Cancer Med; 2021 Sep 13; 10(18):6546-6560. PubMed ID: 34382341
    [Abstract] [Full Text] [Related]

  • 9. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
    Qiu P, Guo Q, Yao Q, Chen J, Lin J.
    Front Immunol; 2021 Sep 13; 12():736030. PubMed ID: 34659224
    [Abstract] [Full Text] [Related]

  • 10. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D, Wei G, Ma J, Cheng S, Jia L, Song X, Zhang M, Ju M, Wang L, Zhao L, Xin S.
    BMC Cancer; 2021 May 31; 21(1):645. PubMed ID: 34059009
    [Abstract] [Full Text] [Related]

  • 11. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
    Liu J, Wei Y, Wu Y, Li J, Sun J, Ren G, Li H.
    Front Immunol; 2021 May 31; 12():657950. PubMed ID: 33936088
    [Abstract] [Full Text] [Related]

  • 12. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS, Xu CQ, Lv J.
    Bioengineered; 2021 Dec 31; 12(1):1238-1250. PubMed ID: 33843442
    [Abstract] [Full Text] [Related]

  • 13. KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer.
    Liang H, Zhou G, Lv L, Lu J, Peng J.
    Breast Cancer; 2021 Mar 31; 28(2):379-386. PubMed ID: 33067762
    [Abstract] [Full Text] [Related]

  • 14. Development and validation of a mitotic catastrophe-related genes prognostic model for breast cancer.
    Wang S, Zi H, Li M, Kong J, Fan C, Bai Y, Sun J, Wang T.
    PeerJ; 2024 Mar 31; 12():e18075. PubMed ID: 39314848
    [Abstract] [Full Text] [Related]

  • 15. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S, Wei M, Wang S, Dong J, Wei J.
    Front Immunol; 2020 Mar 31; 11():1218. PubMed ID: 32714316
    [Abstract] [Full Text] [Related]

  • 16. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z, Shen Y, Fan D, Liu J, Chen D, Wang K, Xu X.
    Int Immunopharmacol; 2021 Jan 31; 90():107119. PubMed ID: 33243605
    [Abstract] [Full Text] [Related]

  • 17. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
    Ren H, Hu D, Mao Y, Su X.
    Med Sci Monit; 2020 Apr 06; 26():e920212. PubMed ID: 32251269
    [Abstract] [Full Text] [Related]

  • 18. Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.
    Bai F, Jin Y, Zhang P, Chen H, Fu Y, Zhang M, Weng Z, Wu K.
    Aging (Albany NY); 2019 Nov 12; 11(21):9328-9347. PubMed ID: 31715586
    [Abstract] [Full Text] [Related]

  • 19. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.
    Tang M, Rong Y, Li X, Pan H, Tao P, Wu Z, Liu S, Tang R, Liu Z, Cai H.
    BMC Cancer; 2024 Sep 19; 24(1):1163. PubMed ID: 39300389
    [Abstract] [Full Text] [Related]

  • 20. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B, Fan Y, Song Z, Han B, Meng Y, Cao P, Tan K.
    Int Immunopharmacol; 2020 Dec 19; 89(Pt B):107078. PubMed ID: 33049497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.